GLP-1 medications represent a new class of treatment for managing type 2 diabetes and, increasingly, excess loss. Tirzepatidus, Semaglutida, and the newer molecule Retatruid are prominent examples within this group. These medicines work by mimicking the body's natural GLP-1 hormone, stimulating glucose production and suppressing sugar production, u